Journal of internal medicine
-
Multicenter Study
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine.
An observational safety study of the quadrivalent human papillomavirus vaccine (HPV4) in women was conducted. This report presents findings from autoimmune surveillance. Design. Subjects were followed for 180days after each HPV4 dose for new diagnoses of 16 prespecified autoimmune conditions. ⋯ No autoimmune safety signal was found in women vaccinated with HPV4.